What you are comparing
Clinical genetic testing looks at DNA sequence. Germline tests read inherited variants that are largely stable across life. Some tests look for acquired changes in a tumor or blood cells. CDC materials describe medical genetic testing as a way to diagnose a condition, estimate risk, or guide care when the question is specific.
Epigenetic testing in longevity clinics usually means DNA methylation. NHGRI explains that epigenetic marks sit on DNA and can change how genes are used without changing the sequence. Marks differ by tissue and can shift with age, illness, smoking, and cell composition. A saliva or blood clock is a statistical model, not a second genome.
Clinics often sell both as “your genes.” They are not interchangeable. A pathogenic BRCA variant can change imaging and family counseling. A biological-age years number cannot. FDA consumer pages on direct-to-consumer tests also stress that a consumer report is not a diagnosis and may need confirmatory clinical testing.
This comparison is for adults shopping a longevity panel who already have, or are considering, a hereditary question. It is not a prenatal guide and it is not a substitute for oncology or cardiology genetics. If you have a known familial mutation, work with a genetics clinic, not a marketing clock.
How they differ
Stability is the first split. Inherited sequence usually stays the same. Methylation patterns move. That is why clocks are marketed for repeat testing. Repeatability is not the same as clinical action. A three-month swing can reflect cell mix, a cold, weight change, or lab drift.
Purpose is the second split. Clinical genetics answers a named question: Does this variant explain the family cancers? Should relatives be offered testing? NCI’s genetic-testing fact sheet treats those results as medical information that can change surveillance. Clocks estimate a research construct such as “age acceleration.” They do not classify variants or trigger cascade testing.
Counseling and privacy also differ. CDC pages recommend genetic counseling before and after many medical tests because results can affect relatives and next steps. Clock reports rarely include a certified genetic counselor. They may still store identifiable genomic data. Ask who holds the sample, whether it is sold, and how long it is kept.
Regulation and laboratory quality are uneven on both sides. Some clinical assays are FDA-authorized or used as laboratory-developed tests in CLIA labs with clear indications. Many consumer clocks are research-use or wellness products. A colorful age graphic is not evidence that the assay was validated to change statin, screening, or hormone decisions.
- Sequence tests: once, then reinterpret as knowledge changes.
- Methylation clocks: serial scores, model-dependent, not standardized for treatment.
- Clinical genetics: counseling, family implications, confirmatory testing.
- Clock kits: often cash-pay, optional, and easy to over-read.
Who each option is for
Clinical genetic testing may fit when a physician, NP, PA, or genetic counselor sees a specific hereditary pattern: early-onset cancer, multiple related cancers, sudden cardiac death in relatives, or very high cholesterol that suggests familial hypercholesterolemia. The test should name the genes and the action that follows a positive or uncertain result.
A methylation clock may be of research interest if you already have indicated screening, you understand it is a model, and you will not use it to skip a colonoscopy, mammogram, or blood-pressure visit. It is a poor fit if you want a lifespan number, a detox score, or a reason to start hormones or peptides.
People with anxiety about “bad genes” often do better with counseling than with another dashboard. A negative consumer screen can miss the variant that matters. A frightening clock can push supplements that do not treat the actual risk. If you are pregnant or planning pregnancy, use a prenatal or reproductive-genetics path, not a longevity kit.
Neither product is first-line for new lumps, chest pain, unexplained bleeding, or a changing mole. Those need ordinary evaluation. A clock that looks “young” does not make a symptom safe to ignore.
Risks of choosing the wrong one
The main harm of treating a clock as clinical genetics is missed hereditary care. You may skip indicated testing, or you may think a wellness kit already “checked your genes.” CDC notes that no single genetic test finds every condition. The wrong panel is a false reassurance.
The main harm of treating clinical genetics as a lifestyle upgrade is unexpected information without support. You can learn about a variant that affects siblings or children. You may need imaging, risk-reducing surgery discussions, or cascade testing. Doing that from a boutique email is not adequate care.
False precision is another risk. Clock vendors may imply that a one-year change proves the protocol worked. Research reviews of epigenetic clocks, including Horvath and Raj’s overview, treat them as promising biomarkers with technical limits. They are not licenses to delay USPSTF-aligned screening.
Privacy and secondary use matter. Sequence and methylation data are identifying. Ask about research sharing, law-enforcement access, and whether the company can change its policy. Do not assume a longevity brand follows the same counseling and consent standards as a hospital genetics program.
How to decide
Start with the clinical question, not the menu. If the question is hereditary disease, book genetics through licensed care. If the question is “how old am I really,” treat any clock as optional research context after blood pressure, lipids, glucose, and screening are handled.
Ask who interprets the result. For germline tests, that should be a clinician who can order confirmatory testing and refer to counseling. For a clock, ask for the model name, version, tissue, published performance, and the decision it would change. If the only answer is a supplement stack, decline.
Price the follow-up, not just the kit. Clinical genetics can lead to covered surveillance. Clocks often lead to repeat cash tests. Set a stop rule: one optional score is enough unless a research protocol explains why another sample helps.
Keep ordinary prevention. Vaccines, tobacco cessation, blood-pressure treatment, and cancer screening have clearer outcome data than any aging clock. Use licensed care for those. A younger methylation age is not a reason to drop a mammogram or a statin you already need.
Frequently Asked Questions
References
CDC: Genetic Counseling
https://www.cdc.gov/genomics-and-health/counseling-testing/genetic-counseling.htmlCDC: Genetic Testing
https://www.cdc.gov/genomics-and-health/counseling-testing/genetic-testing.htmlFDA: Direct-to-Consumer Tests
https://www.fda.gov/medical-devices/in-vitro-diagnostics/direct-consumer-testsNCI: Genetic Testing Fact Sheet
https://www.cancer.gov/about-cancer/causes-prevention/genetics/genetic-testing-fact-sheetNHGRI: Epigenomics Fact Sheet
https://www.genome.gov/about-genomics/fact-sheets/Epigenomics-Fact-SheetPMC: DNA methylation-based biomarkers and the epigenetic clock theory of ageing
Your Privacy Choices